Enhanced molecular mimicry of CEA using photoaffinity crosslinked C3d peptide

Nature Biotechnology

Volumn 16, Issue 5, 1998, Pages 458-462

  Lou, Dingyuan ^a,b   Kohler, Heinz ^a,b  

^a Immpheron Incorporated   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Anti idiotype antibody; Molecular peptide adjuvant; Vaccine development

Indexed keywords

ADJUVANT; ANTIIDIOTYPIC ANTIBODY; CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; PEPTIDE;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; HUMAN; HUMAN CELL; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN CROSS LINKING; VACCINE PRODUCTION;

ADENOSINE; AFFINITY LABELS; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AZIDES; B-LYMPHOCYTES; BLOTTING, WESTERN; CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; COMPLEMENT C3D; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; PEPTIDES; RECEPTORS, COMPLEMENT 3D; SPLEEN;

EID: 0031954004     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0598-458     Document Type: Article

References (27)

1. Bhattacharya-Chatterjee, M., Mukerjee, S., Biddle, W., Foon, K.A., and Kohler, H. 1990. Syngeneic monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen. J. Immunol. 145:2758-2765.
2. Bhattacharya-Chatterjee, M., Mrozek, E., Mukerjee, S., Ceriani, R.L., Kohler, H., and Foon, K.A. 1994. Anti-idiotype antibodies as potential therapeutic agents for human breast cancer. Adv. Exp. Med. Biol. 353:139-148.
3. Bhattacharya-Chatterjee, M., Foon, K.A. and Kohler, H. 1994. Idiotypic antibody immunotherapy of cancer. Cane. Immunol. Immunother. 38:75-82.
4. Kohler, H., Kaveri, S., Kieber-Emmons, T., Morrow, W.J.W., Muller, S., and Raychaudhuri, S. 1989. Overview of idiotypic networks and the nature of molecular mimicry. Methods Enzymol. 178:3.
5. Chatterjee, M., Foon, A.K., Muckerjee, S., Petrelli, N., and Kohler, H. 1993. Idiotype matching: A network antigen idiotype is expressed in colon cancer patient's sera. Vaccine Research 2:283-290.
6. Chakraborty, M., Foon, K.A., Kohler, H., and Bhattacharya-Chatterjee, M. 1995. Preclinical evaluation in non-human primates of an anti-idiotypic antibody that mimics the carcinoembryonic antigen. Journal of Immune-therapy 18:95-103.
7. Foon, K.A., Chakraborty, M., John, W.J., Sherratt, A., Kohler, H., and Bhattacharya-Chatterjee, M. 1995. Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J. Clin. Invest. 96:334-342.
8. Bhattacharya-Chatterjee, M. and Kohler, H. 1989. Anti-idiotype tumor vaccines. Adv. Exp. Med. Biol. 251:113-127.
9. Dempsey, P.W., Allison, M.E.D., Akkaraju, S., Goodnow, C.C., and Fearon, D.T. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348-350.
10. Fearon, D.T. and Carter, R.H. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Anna. Rev. Immunol. 13:127-149.
11. Rickert, R.C., Rajewski, K., and Roes, J.B. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:325-355.
12. Tao, M.-H. and Levy, R. 1993. Idiotype/granulcoyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362:755-758.
13. Lambris, J.D., Ganu, V.S., Hirani, S. and Muller-Eberhard, H.J. 1985. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc. Natl. Acad. Sci. USA 82:4235-4239.
14. Rajagopalan, K., Pavlinkova, G., Levy, S., Pokkuluri, P., Schiffer, M., Haley, B.E., and Kohler, H. 1996. Novel unconventional binding site in the variable domain of immunoglobulins, Proc. Natl. Acad. Sci. USA 93:6019-6024.
15. Pavlinkova, G., Rajagopalan, K., Muller. S., Chavan, A., Sievert, G.D., Lou, D. et al. 1997. Site-specific photobiotinylation of immunoglobulins, fragments and light chain dimers. J. Immunol. Methods 201:77-88.
16. Antoni, G.R., Presentini, F., Perin, A., Taglibue, P., Ghire. S., Censini, G. et al. 1986. A short synthetic peptide fragment of human interleukin I with immunostimulatory but not inflamatory activity. J. Immunol. 137:3201-3206.
17. Bona, C., Herber-Katz, E., and Paul, W.E. 1981. Idiotype-and anti-idiotype regulation. Immuniztion with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-anti-idiotype) antibodies and to activation of silent clones. J. Exp Med. 153:951-967.
18. Herlyn, D., Wettendorff, M., Schmoll, E., lliopoulos, D., Schedel, I., Dreikhausen, U. et al. 1990. Anti-idiotype immunization of cancer patients: modulation of the immune response. Proc. Natl. Acad. Sci. USA 84:8055-8059.
19. Mittelman, A., Chen, Z.J., Yang, H., Wong, G.Y., and Ferrone, S. 1992. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotype antibody MK2-23: induction of humoral anti-HMW-MAAA immunity and prolongation of survival in patients with stage IV melanoma. Proc. Natl. Acad.Sci. USA 89:466-1215.
20. Mittelman, A., Chan, Z.J., Lia, C.C., Hirari, S., and Ferrone, S. 1994. Kinetics of the immune response and regression following development of humoral antihigh molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res. 15:415-421.
21. Denton, G.W., Durrant, L.G., Hardcastle, J.D., Ahstin, E.B., Sewell, H.F., and Robins, R.A. 1994. Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int. J. Cancer 57:10-14.
22. Hebell, T., Ahearn, J.M., and Fearon, D.T. 1991. Suppression of immune response by soluble complement receptor of B lymphocytes. Science 254:102-105.
23. Hakim, I., Levy S., and Levy R. 1996. A nine-amino acid peptide from IL-1 b augments antitumor immune responses induced by protein and DNA vaccines. J. Immunol. 157:5503-5511.
24. Becker, J.C., Varki, N., Gillies, S.D., Furukawa. L., and Reisfeld, R.A. 1996. An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response. Proc. Natl. Acad. Sci. USA 93:7826-7831.
25. Zanetti, M. 1992. Antigenized antibodies. Nature 355:466-477.
26. Zaghouani, H., Krystal, M., Kuzu, H., Moran, T., Shah, H., Kuzu, Y et al. 1992. Cells expressing an H chain Ig gene carrying a viral T cell epitope are lysed by specific cytolytic T cells J. Immunol. 148:3604-3609.
27. Zaghouani, H., Anderson, S.A., Sperber, K.E., Daian, C., Kennedy, R.C., Mayer, L., and Bona C.A. 1995. Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Proc. Natl. Acad. Sci. USA 92:631-635.